``````json
{
" "content"":": [
{
"type":": "list",
"title":": Growth",
" items":[
{
"text":":"* Regulatory-driven Accelerations—Accelerated FDA/EMA conditional Approvals for for‑inpatient agents such as** ************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************************** }},
{
"text":":" Rising prevalence of congenital Hyperinsulinism driven by improved Neonatal screening and genetic‑testing adoption expands the Cong********************************************************************************************************************************************************************************************************************************************************** ************````
}
]
},
{
""type":": list",
"title":": Restraers",
" items":[
{
"text":":" *High reimbursement pressure—********** "
},
{
"text":":" *Limited**********************************************"
}
]
},
{
{
"type":": list",
: "title": : Opportunities",
"items":[
{
"text":" *Emerging******************************************** "
},
{
"text":" *********************************************************"
}
]
},
{
""type":": list",
"title":"Challenges",
"items":[
{
"text":" *********************************************"
},
{
"text":" *********************************"
}
}
]
}
````
